- Open Access
DAXX modulates human papillomavirus early gene expression and genome replication in U2OS cells
Virology Journal volume 12, Article number: 104 (2015)
The human papillomavirus (HPV) genomes can replicate, and are maintained as autonomously replicating extrachromosomal plasmids in human U2OS cells. Previous studies have shown that HPV genomes are transcriptionally active in U2OS cells and can express the viral early proteins required for initiation and establishment of HPV replication. In the present work, we have examined the involvement of cellular DAXX protein in HPV replication in U2OS cells.
We have used indirect immunofluorescence and FISH analysis in order to study HPV replication compartments in U2OS cells. In addition, we have used siRNA knock-down for examining the effect of the DAXX protein on HPV replication and transcription in U2OS cells.
We show that a portion of HPV replication foci are partially co-localized with components of ND10, cellular DAXX and PML proteins. In addition, we demonstrate that the knock-down of the cellular DAXX protein modulates the HPV genome replication and transcription in U2OS cells – papillomavirus replication is reduced in the absence of this component of ND10.
The DAXX protein modulates the early gene expression and the transient replication of HPV genomes in U2OS cells.
Papillomaviruses are small, double-stranded DNA viruses which infect the epithelial tissue of a wide variety of vertebrates and induce proliferative lesions of the skin and mucosa. The human papillomavirus (HPV) high-risk types, such as HPV16, 18 and 31, are associated with anogenital cancer, and are the primary aetiological agents for cervical carcinoma. Low-risk types, for instance HPV6 or 11, can cause genital warts . Papillomaviruses establish long-term persistent infection in stratified squamous epithelium. The viral life cycle is tightly linked to the differentiation status of the host cells. After infection of the basal cells of the epithelium, the viral genome is replicated until an optimal copy number is reached. This is called the initial amplification, or establishment phase, of PV replication. It is followed by a maintenance phase, during which a constant copy number of extrachromosomal viral genomes is maintained in the nuclei of host cells as they divide. The viral E1 and E2 proteins, together with the host cell replication machinery, are responsible for HPV DNA replication at both early stages of virus replication [reviewed in .
Many DNA viruses replicate their genomes in close proximity to ND10. It has been suggested that ND10 is important for antiviral defense and is a part of the intrinsic immune system . Swindle and others have demonstrated that HPV11 replication compartments partially overlap with PML in C33A cells . However, the functional role of ND10 in papillomavirus infection is still controversial. In the case of BPV1, ND10 seems to positively affect papillomavirus infectivity as the presence of PML and intact ND10 are associated with enhanced BPV1 early gene expression . Yet others have shown that PML and ND10 are not required for HPV DNA replication in transfected cells . More recent data show that ND10 proteins have opposing roles in viral transcription; SP100 knock-down enhances HPV18 early transcription in primary human keratinocytes, while PML and DAXX knock-down decreases it .
One component of the ND10 is the DAXX protein, which is a highly conserved nuclear protein involved in regulation of apoptosis and gene expression . It is predominantly located in the cell nucleus, where it is associated with two nuclear domains: the ND10 and condensed heterochromatin . In transcription regulation, the DAXX protein functions mainly as a co-repressor. It associates with histone deacetylases (HDACs), DNA methyltransferases (DNMTs), core histones, DEK, ATRX and other chromatin-associated factors [10–13], suggesting that it represses transcription through modification of chromatin. The repressive function of DAXX has been associated with cellular intrinsic immune response against incoming viruses. Through the action of HDACs, DAXX silences immediate-early (IE) gene expression of human cytomegalovirus (HCMV) by inducing a transcriptionally inactive chromatin state around the major IE promoter [3, 14, 15]. The DAXX protein is also involved in negative regulation of adenovirus (Ad5) replication , and initiation and maintenance of retroviral silencing, which is facilitated by HDACs and DNMTs recruitment to retroviral (ASV-1, HIV-1) DNA [13, 17, 18].
Most established human cell lines fail to support HPV genome replication. However, both alphapapillomaviruses, including HPV11 and 18, and betapapillomaviruses are able to replicate extrachromosomally and establish a stable replication in the human osteosarcoma cell line U2OS . U2OS cells are not the natural host cells of papillomaviruses, but these cells appear to contain all the necessary cellular factors required for the replication of papillomavirus genomes, and therefore provide a cost-effective system for studying the fundamental processes of papillomavirus replication. In our present work, we have examined the HPV replication foci in U2OS cells in relation to ND10, and the effect of one component of ND10, the DAXX protein, on HPV genome replication and transcription. We show that the DAXX protein modulates the early gene expression and the transient replication of HPV genomes in these cells.
HPV replication foci in U2OS cells
The replication of HPV genomes occurs within the distinct replication compartments in the nuclei of U2OS cells . Both E1 and E2 proteins are required for the initiation of HPV replication within the cells  and are shown to localize in the HPV replication centers . In this study, we have used the mouse monoclonal antibodies against HPV11 E2 and rabbit polyclonal antibodies against HPV18 E1 in order to characterize the HPV replication foci in U2OS cells by indirect immunofluorescence analysis. These antibodies allow us to detect the corresponding HPV proteins expressed by the HPV minicircle genomes.
First, we analyzed the involvement of cellular BRD4 protein in HPV replication in U2OS cells. BRD4 localizes to, and is essential for the formation of HPV replication foci in primary human foreskin keratinocytes. However, when E1 and E2 begin to amplify the viral DNA, BRD4 is displaced from the foci . In order to test whether this is also the case in U2OS cells, we performed an immunofluorescence assay. Six days after transfection with 2 μg of wt HPV11 minicircle genomes, the cells were fixed and immunostained for HPV11 E2 and BRD4 proteins. As shown in Fig. 1, the individual U2OS cells contained different number of HPV11 E2 foci (Fig. 1 HPV11 E2 column). We detected up to ten HPV11 E2 foci, with an average value of four foci per cell nucleus. The HPV replication foci also had a different size. The small HPV11 E2 foci co-localized with the cellular BRD4 protein (Fig. 1a), and were reminiscent of the small early HPV replication foci that were described in human keratinocytes by Sakakibara and others . Large HPV11 E2 foci were also visible in U2OS cells at the same time-point, and the cellular BRD4 protein was absent from these foci (Fig. 1b). Overall, this indicates the involvement of BRD4 in the early steps of replication foci formation in U2OS cells, similar to what has been observed in human keratinocytes .
HPV replication foci localization in relation to ND10 in U2OS cells
The main aim of this work was to analyze the localization of HPV replication centers in relation to components of ND10 in U2OS cells. Many DNA viruses replicate their genomes in close proximity to ND10, and several reports link multiple stages of HPV infection with these nuclear sites [4, 5, 22, 23]. However, the role of ND10 in papillomavirus infection is still controversial. In order to analyze the link between HPV replication and ND10 in U2OS cells, we first analyzed the localization of the HPV E2 protein and cellular DAXX protein, a constitutive component of ND10. For this purpose, U2OS cells were transfected with 2 μg of wt HPV11 minicircle genomes, fixed six days later and immunostained for HPV11 E2 and cellular DAXX proteins. On average, seven DAXX-containing foci per cell nucleus were observed (Fig. 2 DAXX column), and 34 % of the E2 foci overlapped partially with DAXX-containing foci. Representative images of cells with different number and size of HPV11 E2 foci and DAXX staining are shown in Fig. 2a and b. A similar analysis with HPV18 replication centers failed due to the fact that we were unable to find mouse monoclonal antibodies against the DAXX protein suitable for immunofluorescence analysis. Therefore, we performed immunofluorescence analysis coupled with FISH detection of HPV18 DNA. U2OS cells were transfected with 5 μg of wt HPV18 minicircle genomes and fixed six days later. The cells were immunostained for DAXX protein and HPV DNA was detected with an HPV18 specific probe (Fig. 2c). We observed at least partial co-localization of DAXX and HPV DNA in 22 % of the HPV18 DNA foci in U2OS cells.
In order to confirm the partial co-localization of HPV replication centers and ND10, immunofluorescence analysis was performed with another component of ND10, the PML protein. First U2OS cells were transfected with 2 μg of wt HPV11 minicircle genomes and immunostained for HPV11 E2 and cellular PML proteins. The PML signal was observed in a punctate pattern in the cell nucleus, with an average of 14 PML structures per nucleus (Fig. 3a, b; PML column). 44 % of the E2 foci overlapped partially with PML-containing foci. In many cases, HPV replication foci and ND10 localized side by side. Representative images of cells with different number and size of HPV11 E2 foci and PML staining are shown in Fig. 3a and b. A similar analysis was performed with HPV18; however, in this case the immunofluorescence analysis was carried out with HPV18E8- genome. The HPV18E8- mutant replicates at a higher level than the wt HPV18 genome [24, 25], resulting in a higher and more easily detectable HPV18 E1 protein level in the transfected cells. In the case of the HPV18E8- genome, we detected up to 24 E1 foci per cell nucleus, with an average of 10 foci per cell. Examples of typical cells with different sizes of E1 foci are shown in Fig. 3c, d, e and f. 42 % of the E1 foci overlapped, at least partially, with PML signal in U2OS cells six days after transfection. However, in most of the cells, there was no perfect co-localization of HPV18 E1 protein and PML signals; rather, a portion of the E1 foci overlapped with PML partially. In a few cells, we were able to detect very small E1 foci surrounded by the PML protein, as shown in Fig. 3c.
In summary, our immunofluorescence analyses indicate that a fraction of HPV replication foci localize in proximity of components of ND10, the DAXX and PML proteins in U2OS cells.
DAXX modulates the transient replication of HPV genomes in U2OS cells
In order to analyze the involvement of the DAXX protein in HPV genome replication in U2OS cells, we knocked down the expression of DAXX with siRNA and transfected the cells with wt HPV11 and wt HPV18 genomic DNA. Episomal DNA was isolated 72 h after transfection, and the newly replicated HPV11 and HPV18 viral DNA was analyzed by Southern blot (Fig 4a and b). Down-regulation of DAXX repressed the initial replication of both HPV11 and HPV18 genomes. We also analyzed the HPV DNA levels by quantitative real-time PCR, using mitochondrial DNA as an internal control. Consistent with Southern blot analysis, the quantitation of replication products by real-time PCR indicated that down-regulation of the DAXX protein reduced HPV DNA replication by 2-3-fold (Fig. 4c). The level of DAXX protein in U2OS cells treated with siDaxx or siCtr is shown in Fig. 4d.
DAXX modulates HPV early gene expression in U2OS cells
The HPV genomes are transcriptionally active in U2OS cells and express all the viral early proteins required for initiation and establishment of HPV replication [19, 26]. In order to determine whether the DAXX protein is involved in papillomavirus early promoter regulation, we studied the expression of viral early genes that were transcribed from wt HPV18 and wt HPV11 episomes in U2OS cells. Four different primer pairs were used to measure the activity of HPV early promoters. E6, E7, E1 and E2 primers target the corresponding coding sequences in the viral genome (Fig. 5d). Most of these primers target multiple HPV transcripts in U2OS cells . HPV18 E6 primers detect six differently spliced transcripts from early promoter P102; HPV18 E7 primers detect the same six transcripts, along with an additional three transcripts from promoter P520. HPV18 E1 primers detect a single E1 encoding transcript originating from promoter P102, and HPV18 E2 primers detect transcripts from three different promoters (P102, P811 and P1193). HPV11 primers were targeted to similar positions in the HPV11 genome.
U2OS cells were first transfected with siCtr or siDaxx, and twenty-four hours later, the cells were electroporated with 2 μg of either wt HPV11 or 18 DNA. After an additional 48 hours, RNA was extracted and the HPV transcript levels were analyzed. In order to compare the level of viral early promoters of HPV18 and HPV11 genomes, the viral transcript signals were expressed relative to cellular HPRT1 mRNA level. The HPV11 early promoters were more active when compared to HPV18 in U2OS cells, which is consistent with the replication efficiency of HPV 11 and 18 genomes in U2OS cells (Fig. 4). siDaxx treatment of U2OS cells prior to transfection with HPV18 DNA decreased the viral early gene expression by approximately 2-fold (Fig. 5a and c). Similar results were obtained with the HPV11 genome (Fig. 5a). The knock-down of DAXX did not influence the expression level of cellular housekeeping gene beta-actin (Fig. 5b). In summary, our data indicate that DAXX knock-down leads to a reduction in virus early gene expression.
In this study, we have examined the HPV replication foci in relation to cellular ND10 in U2OS cells. HPV replication foci, containing the viral genome, virus early proteins required for initiation of the replication, and cellular components ensuring the efficient propagation of the virus, are formed at specific sites in the nucleus. Our results indicate that a portion of HPV replication centers co-localize partially with components of the ND10, the DAXX and PML proteins. This is consistent with the work of Swindle et al. , who have previously shown that in C33A cells transfected with HPV11 viral ori sequence and E1 and E2 expression vectors, the viral proteins co-localize, at least partially, with PML in a portion of the cells. In addition, Rivera-Molina and others have demonstrated that HPV11 DNA/E2 protein complex recruits ND10 proteins, HPV DNA/protein complex co-localized with DAXX independently of PML, and with PML independently of the DAXX protein . These data confirm that papillomavirus genomes replicate in close proximity to ND10.
Several other DNA viruses (herpes simplex virus type 1, simian virus 40, human adenovirus type 5) replicate and transcribe predominantly at close proximity to ND10 . These similarities might originate from the requirement to control common cellular factors that participate in viral genome replication or transcription. Components of ND10 are interferon inducible transcriptional repressors, and are believed to form a nuclear defense mechanism against viruses. As a result, most DNA viruses have developed mechanisms to antagonize the restrictive function of ND10 . In the case of papillomaviruses, however, the interaction with ND10 is controversial. The DAXX protein appears to have a positive role in HPV transcription and regulation. Our results show that knock-down of one component of ND10, the cellular DAXX protein, leads to reduced HPV11 and HPV18 early transcription and viral replication in U2OS cells. This result is consistent with a more detailed study by Stepp and others  of the roles of three components of ND10 in the early stages of HPV18 infection in primary human keratinocytes; PML, SP100 and DAXX. They revealed that PML and DAXX knock-down leads to a reduction in HPV18 transcription, while SP100 behaves as a repressor of viral infection. The presence of PML and intact ND10 is also associated with enhanced BPV1 early gene expression .
Recent work from different groups has demonstrated that HPV infection triggers the host cell DNA damage response (DDR) by activating the ATM-Chk2-dependent pathway [25, 30–32]. Activation of ATM is necessary for efficient, productive amplification of HPV . Many of the DDR proteins that co-localize with HPV replication compartments also associate with PML and have the potential to reside in ND10 and, along with PML, relocate to sites of DNA damage (reviewed in ). The ND10 may therefore form a depot of cellular proteins that are involved in viral replication or transcription, and this could explain why the cellular environment around ND10 could be particularly advantageous for the papillomavirus during certain stages of the viral life cycle. The ND10 can act as DNA damage sensors that go through structural changes, increasing in their numbers in response to DNA damage . Indeed, it has been shown that within the poorly differentiated basal and parabasal layers of the stratified epithelia, where the early stage of the viral life cycle takes place, the number of ND10 is increased in the presence of HPV genomes .
While the replication of HPV origin-containing plasmids can be reconstituted in many cell types by expressing viral replication proteins E1 and E2 from heterologous plasmids, most of the established human cell lines fail to support HPV genome replication . Papillomaviruses have the capacity to establish long-term persistent infection in U2OS cells. This is achieved through the interplay between viral and cellular factors involved in virus gene expression and genome replication. We have shown that, similar to human keratinocytes, in U2OS cells the BRD4 protein is localized in HPV replication foci in the beginning of replication and is displaced when the foci increase in size. HPV replication centers in U2OS cells contain markers of homologous recombination similar to HPV31 foci in human keratinocytes [25, 32, 33]. All these data suggest that the HPV replication and cellular mechanism triggered by it, is similar both in human keratinocytes and in a model cell line U2OS.
The analysis of HPV replication foci in U2OS cells indicated that HPV replication compartments overlap partially with the DAXX and PML proteins and the early replication is modulated by the DAXX protein. This further confirms that HPV replication has many common features in U2OS cells and primary human keratinocytes, suggesting that U2OS cell line is suitable for studying the basic mechanisms of papillomavirus replication.
Materials and methods
The siRNA target sequence for human Daxx (5′-GGAGUUGGAUCUCUCAGAA) has been published previously . As a control siRNA (siCtr), non-specific siRNA (5’ CCCUGUCAGUAUUGAUAGAAA) was used. Both siRNAs were purchased from Sigma-Aldrich.
Cell lines and transfections
U2OS cells obtained from the American Type Culture Collection (ATCC) (number HTB-96) were cultured in Iscove’s modified Dulbecco’s medium supplemented with 10 % of fetal calf serum. The transfections were carried out either by electroporation as described in , applying 180 V or by lipofection using LipofectamineTM RNAiMAX as a transfection reagent according to manufacturer’s protocol (Invitrogen).
For transfection, the pBRHPV18 and pUCHPV11 plasmids [19, 30] were digested with EcoRI and BamHI to release the wt HPV18 and wt HPV11 genome, respectively; linear genomes were gel-purified, re-ligated and concentrated by ethanol precipitation . 4 × 105 of U2OS cells were seeded onto 60 mm dishes the day before transfection with 200 pmol of siDaxx and siCtr siRNA duplexes by LipofectamineTM RNAiMAX. Transfected U2OS cells were counted 24 h post-transfection and an even count of cells was transfected by electroporation with 2 μg of circularized HPV18 or HPV11 genome and incubated for another 72 h. The cells were collected, counted and low molecular weight DNA was isolated from an even amount of cells. 4/5th of the recovered DNA was cut with DpnI, which digests only unreplicated DNA, and a linearizing enzyme (EcoRI or BamHI) and analyzed by Southern blot analysis as described in . 1/65th of the remaining DNA was subjected to qPCR analysis – DNA isolated from U2OS cells was cut with DpnI. The primers chosen for qPCR analysis contained a DpnI site in the amplified region so that only newly synthesized DNA was analyzed.
2.5 × 105 of U2OS cells were seeded onto 60 mm dishes the day before transfection with 200 pmol of siDaxx and siCtr siRNA duplexes by LipofectamineTM RNAiMAX. U2OS cells were counted 24 h post-transfection and an even count of cells was transfected by electroporation with 2 μg of circularized wt HPV18 or wt HPV11 genome and incubated for another 48 h. RNA was isolated using TRIZol® reagent (Invitrogen) according to the directions of the manufacturer. 5 μg of DNase I-treated total cellular RNA was used in reverse transcription reactions with oligo(dT)18 primers using First Strand cDNA Synthesis Kit (Fermentas). The reaction products were treated with RNase H (Fermentas). 1/40th of the cDNA was used for analysis by qPCR.
Quantitative real-time PCR was performed using HOT FIREPol® EvaGreen® qPCR Mix (Solis BioDyne). All samples were analyzed in triplicate and the target sequences were amplified for 40 cycles using the following primer pairs:
HPV18 (ATAGGTTGGGCAGCACATAC and CAGTTCCGTGCACAGATCAG); HPV11 (TCCATTGCTGAACCTACTAC and CATTTTAAACAAGCGGAATCACCTTGCAG); mtDNA (CACTCCACGGAAGCAATATG and GTGTCGTGTAGTACGATGTC).
HPV18 E6 (TGCGGTGCCAGAAACCGTTG and GCTCGGTTGCAGCACGAATG), HPV18 E7 (GCCGAACCACAACGTCACAC and GCTGCTGGAATGCTCGAAGG), HPV18 E1 (AGCAGACAGCAACAGCAATG and CGCAGGAATTGCACTATTGG), HPV18 E2 (AGGAAGATGCAGACACCGAAG and GGCTGTCTATGTCTTTACTGTC), HPV11 E6 (AGCGTGTGCCTGTTGCTTAG and CGTGCCTTTCCCAATATGTG), HPV11 E7 (GGTGGACAAGGTGGACAAAC and ATGTCTCCGTCTGTGCACTC), HPV11 E1 (ACCGTGGCACGTACATTAGG and TAACGGTCTGGCGCGTTATC), HPV11 E2 (GAGCCACATCGGGTTACAAG and ACCGTTTGGGTGGTGTTAGC), HPRT1 (GACTTTGCTTTCCTTGGTCAGG and AGTCTGGCTTATATCCAACACTTCG), bACT (CTGGAACGGTGAAGGTGACA and CGGCCACATTGTGAACTTTG).
For immunoblotting analysis, the cells were washed twice with PBS, detached with PBS-EDTA and lysed with SDS loading buffer. Material from equal number of cells was loaded on each lane, proteins were separated by SDS-polyacrylamide gel electrophoresis and transferred by a semi-dry blotting method to a polyvinylidene difluoride membrane (Millipore Corp). Membranes were incubated with rabbit anti-Daxx antibody (1:8,000; Sigma-Aldrich) and mouse monoclonal anti-tubulin antibody (1:20,000; Sigma-Aldrich); unconjugated primary antibodies were visualized with secondary anti-mouse and anti-rabbit IgG antibodies conjugated with horseradish peroxidase (1:10,000; Icosagen). Chemoluminescent signal was detected using ECL kit from Amersham Biosciences.
HPV minicircle genomes were used in immunofluorescence analysis. The construction and production of minicircle HPV genomes has been described in . U2OS cells were electroporated with 2 μg of wt HPV11 or HPV18E8- minicircle viral genomes and grown on microscope slides. 6 days after electroporation cells were fixed with 4 % paraformaldehyde for 10 min and IF analysis was performed as described in Reinson et al. . IF was performed with the following primary antibodies using indicated dilutions: DAXX (D7810; Sigma-Aldrich) 1:100; PML (sc-966; Santa Cruz Biotechnology) 1:100; PML (sc-5621; Santa Cruz Biotechnology) 1:50; rabbit polyclonal antibodies BRD4B and BRD4C  at final concentration 10 ng/μl; HPV11 E2 (ab100968, Abcam) at final concentration 20 ng/μl; and rabbit polyclonal antibody HPV18 E1  at final concentration 20 ng/μl. Secondary antibodies Alexa Fluor® 568 Goat Anti-Rabbit IgG (A-11011); Alexa Fluor® 568 Goat Anti-Mouse (A-11004); Alexa Fluor® 488 Goat Anti-Rabbit IgG (A-11008); and Alexa Fluor® 488 Goat Anti-Mouse (A-10680) were used at a dilution 1:1000 and were purchased from Invitrogen. Cells were placed under coverslips with SlowFade® Gold antifade reagent with DAPI (Invitrogen) and analysis was performed with Zeiss confocal microscope LSM710 using 63x oil-immersion objective.
U2OS cells were electroporated with 5 μg of wt HPV18 minicircle viral genomes  and grown on microscope slides. 6 days after electroporation cells were fixed and IF analysis followed by FISH was performed as described by Reinson et al. . IF was performed with primary antibody anti-DAXX (D7810; Sigma-Aldrich) 1:100 and secondary antibody Alexa Fluor 568 Goat Anti-Rabbit IgG (A-11004; Invitrogen) 1:1000; HPV DNA was detected with HPV18 specific probe. Cells were placed under coverslips with SlowFade® Gold antifade reagent with DAPI (Invitrogen) and analysis was performed with Zeiss confocal microscope LSM710 using 63x oil-immersion objective.
Zur Hausen H. Papillomavirus infections--a major cause of human cancers. Biochim Biophys Acta. 1996;1288(2):F55–78.
Kadaja M, Silla T, Ustav E, Ustav M. Papillomavirus DNA replication - from initiation to genomic instability. Virology. 2009;384(2):360–8.
Tavalai N, Stamminger T. New insights into the role of the subnuclear structure ND10 for viral infection. BBA. 1783;2008:2207–21.
Swindle CS, Zou N, Van Tine BA, Shaw GM, Engler JA, Chow LT. Human papillomavirus DNA replication compartments in a transient DNA replication system. J Virol. 1999;73(2):1001–9.
Day PM, Baker CC, Lowy DR, Schiller JT. Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc Natl Acad Sci U S A. 2004;101(39):14252–7.
Nakahara T, Lambert P. Induction of promyelocytic leukemia (PML) oncogenic domains (PODs) by papillomavirus. Virology. 2007;366(2):316–29.
Stepp W, Meyers J, McBride A. Sp100 provides intrinsic immunity against human papillomavirus infection. mBio. 2013;4(6):e00845-00813.
Salomoni P, Khelifi A. Daxx: death or survival protein? Trends Cell Biol. 2006;16:97–104.
Ishov A, Sotnikov A, Negorev D, Vladimirova O, Neff N, Kamitani T, et al. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol. 1999;147(2):221–34.
Hollenbach A, McPherson C, Mientjes E, Iyengar R, Grosveld G. Daxx and histone deacetylase II associate with chromatin through an interaction with core histones and the chromatin-associated protein Dek. J Cell Sci. 2002;115:3319–30.
Li H, Leo C, Zhu J, Wu X, O'Neil J, Park E, et al. Sequestration and inhibition of Daxx-mediated transcriptional repression by PML. Mol Cell Biol. 2000;5:1784–96.
Puto L, Reed J. Daxx represses RelB target promoters via DNA methyltransferase recruitment and DNA hypermethylation. Genes Dev. 2008;22:998–1010.
Poleshko A, Palagin I, Zhang R, Boimel P, Castagna C, Adams P, et al. Identification of cellular proteins that maintain retroviral epigenetic silencing: evidence for an antiviral response. J Virol. 2008;82(5):2313–23.
Saffert R, Kalejta R. Human cytomegalovirus gene expression is silenced by Daxx-mediated intrinsic immune defense in model latent infections established in vitro. J Virol. 2007;81(17):9109–20.
Woodhall D, Groves I, Reeves M, Wilkinson G, Sinclair J. Human Daxx-mediated repression of human cytomegalovirus gene expression correlates with a repressive chromatin structure around the major immediate early promoter. J Biol Chem. 2006;281(49):37652–60.
Schreiner S, Wimmer P, Sirma H, Everett R, Blanchette P, Groitl P, et al. Proteasome-dependent degradation of Daxx by the viral E1B-55 K protein in human adenovirus-infected cells. J Virol. 2010;84(14):7029–38.
Shalginskikh N, Poleshko A, Skalka A, Katz R. Retroviral DNA methylation and epigenetic repression are mediated by the antiviral host protein Daxx. J Virol. 2013;87(4):2137–50.
Greger J, Katz R, Ishov A, Maul G, Skalka A. The cellular protein daxx interacts with avian sarcoma virus integrase and viral DNA to repress viral transcription. J Virol. 2005;79(8):4610–8.
Geimanen J, Isok-Paas H, Pipitch R, Salk K, Laos T, Orav M, et al. Development of a cellular assay system to study the genome replication of high- and low-risk mucosal and cutaneous human papillomaviruses. J Virol. 2011;85(7):3315–29.
Ustav M, Stenlund A. Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames. EMBO J. 1991;10(2):449–57.
Sakakibara N, Chen D, Jang M, Kang D, Luecke H, Wu S, et al. Brd4 is displaced from HPV replication factories as they expand and amplify viral DNA. PLoS Pathog. 2013;9(11), e1003777.
Day P, Roden R, Lowy D, Schiller J. The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains. J Virol. 1998;72(1):142–50.
Heino P, Zhou J, Lambert P. Interaction of the papillomavirus transcription/replication factor, E2, and the viral capsid protein, L2. Virology. 2000;276(2):304–14.
Kurg R, Uusen P, Vosa L, Ustav M. Human papillomavirus E2 protein with single activation domain initiates HPV18 genome replication, but is not sufficient for long-term maintenance of virus genome. Virology. 2010;408(2):159–66.
Reinson T, Toots M, Kadaja M, Pipitch R, Allik M, Ustav E, et al. Engagement of the ATR-dependent DNA damage response at the human papillomavirus 18 replication centers during the initial amplification. J Virol. 2013;87(2):951–64.
Toots M, Männik A, Kivi G, Ustav MJ, Ustav E, Ustav M. The transcription map of human papillomavirus type 18 during genome replication in U2OS cells. PLoS One. 2014;9(12), e116151.
Rivera-Molina Y, Rojas B, Tang Q. Nuclear domain 10-associated proteins recognize and segregate intranuclear DNA/protein complexes to negate gene expression. Virol J. 2012;9:222.
Ishov A, Maul G. The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. J Cell Biol. 1996;134(4):815–26.
Schmid M, Speiseder T, Dobner T, Gonzalez R. DNA virus replication compartments. J Virol. 2014;88(3):1404–20.
Kadaja M, Isok-Paas H, Laos T, Ustav E, Ustav M. Mechanism of genomic instability in cells infected with the high-risk human papillomaviruses. PLoS Pathog. 2009;5(4), e1000397.
Moody C, Laimins L. Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation. PLoS Pathog. 2009;5(10), e1000605.
Sakakibara N, Mitra R, McBride A. The papillomavirus E1 helicase activates a cellular DNA damage response in viral replication foci. J Virol. 2011;85(17):8981–95.
Anacker D, Gautam D, Gillespie K, Chappell W, Moody C. Productive replication of human papillomavirus 31 requires DNA repair factor Nbs1. J Virol. 2014;15:8528–44.
Everett R. Interactions between DNA viruses, ND10 and the DNA damage response. Cell Microbiol. 2006;8(3):365–74.
Dellaire G, Ching R, Ahmed K, Jalali F, Tse K, Bristow R, et al. Promyelocytic leukemia nuclear bodies behave as DNA damage sensors whose response to DNA double-strand breaks is regulated by NBS1 and the kinases ATM, Chk2, and ATR. J Cell Biol. 2006;175(1):55–66.
Chiang C, Ustav M, Stenlund A, Ho T, Broker T, Chow L. Viral E1 and E2 proteins support replication of homologous and heterologous papillomaviral origins. Proc Natl Acad Sci U S A. 1992;89(13):5799–803.
Chen L, Chen J. Daxx silencing sensitizes cells to multiple apoptotic pathways. Mol Cell Biol. 2003;23:7108–21.
Ustav M, Ustav E, Szymanski P, Stenlund A. Identification of the origin of replication of bovine papillomavirus and characterization of the viral origin recognition factor E1. EMBO J. 1991;10(13):4321–9.
Orav M, Henno L, Isok-Paas H, Geimanen J, Ustav M, Ustav E. Recombination-dependent oligomerization of human papillomavirus genomes upon transient DNA replication. J Virol. 2013;87(22):12051–68.
Ilves I, Maemets K, Silla T, Janikson K, Ustav M. Brd4 is involved in multiple processes of the bovine papillomavirus type 1 life cycle. J Virol. 2006;80(7):3660–5.
We thank Aare Abroi for helpful discussions and critical reading of the manuscript and Mart Toots for technical assistance with IF analysis. This work was supported by institutional research funding (IUT20-27) of the Estonian Ministry of Education and Research, and by the European Regional Development Fund through the Center of Excellence in Chemical Biology.
The authors declare that they have no competing interests.
PK, LV and RK conceived and designed the experiments; PK and LV performed the experiments; PK and LV analyzed the data; MU contributed reagents and materials; PK, LV and RK wrote the paper. All authors read and approved the final manuscript.
Piia Kivipõld and Liisi Võsa contributed equally to this work.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Kivipõld, P., Võsa, L., Ustav, M. et al. DAXX modulates human papillomavirus early gene expression and genome replication in U2OS cells. Virol J 12, 104 (2015). https://doi.org/10.1186/s12985-015-0335-z
- Virus-host interaction